Research Article

Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway

Figure 5

The influence of Rab22a on PI3K/AKT/mTOR signaling pathway. The western blot analysis results revealed that the expression of p-PI3K, p-AKT (Ser473), p-mTOR (Ser2448), and Rab22a induced by Rab22a overexpression or decreased by PI3K inhibitors in TPC1 and K1 (a and b). Statistical data were the of the three repeated independent trials: , , and .
(a)
(b)